Stockholm
Sweden
Karolinska Institutet - Experimental Cancer Medicine
2019 Novel Coronavirus; coronavirus disease 2019; Randomized Controlled Trial Protocol
Interstitial lung disease, pneumonitis, anaplastic lymphoma kinase tyrosine kinase inhibitor, non-small cell lung cancer